These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 29622471)

  • 41. [The practice guideline 'Diabetes mellitus type 2' (second revision) from the Dutch College of General Practitioners; a response from the perspective of internal medicine].
    Holleman F; de Vries JH; Hoekstra JB
    Ned Tijdschr Geneeskd; 2006 Oct; 150(41):2235-7. PubMed ID: 17076356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study.
    Fu H; Curtis BH; Schuster DP; Festa A; Kendall DM
    Diabetes Technol Ther; 2014 Dec; 16(12):833-9. PubMed ID: 25068375
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A real-life study of the use, effectiveness and tolerability of rosiglitazone in France: the AVANCE study.
    Halimi S; Aubert JP; Fontbonne A; Guillausseau PJ; Nachit F; Bouée S; Detournay B
    Diabetes Metab; 2012 Oct; 38(4):343-51. PubMed ID: 22521038
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
    Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
    Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Mismatch between ADA and AGS recommendations for glycated hemoglobin targets for older adults.
    Tasci I; Safer U; Naharci I; Sonmez A
    Prim Care Diabetes; 2018 Apr; 12(2):192-194. PubMed ID: 29396204
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prevalence of insulin as a first-line therapy and associated factors in people with type 2 diabetes in German primary care practices.
    van den Boom L; Kaiser M; Kostev K
    Diabet Med; 2020 Aug; 37(8):1333-1339. PubMed ID: 32506471
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
    Morales J; Assumpcao-Morales M
    Diabetes Obes Metab; 2018 Aug; 20(8):1809-1811. PubMed ID: 29658190
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The target for good glycemic control should be an Hb A(1C) concentration of less than 0.07.
    Matz R
    West J Med; 2000 Sep; 173(3):179-80. PubMed ID: 10986180
    [No Abstract]   [Full Text] [Related]  

  • 49. Diabetes treatment in people with type 2 diabetes and schizophrenia: Retrospective primary care database analyses.
    Rathmann W; Pscherer S; Konrad M; Kostev K
    Prim Care Diabetes; 2016 Feb; 10(1):36-40. PubMed ID: 25937183
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Optimal type 2 diabetes mellitus management: the randomised controlled OPTIMISE benchmarking study: baseline results from six European countries.
    Hermans MP; Brotons C; Elisaf M; Michel G; Muls E; Nobels F;
    Eur J Prev Cardiol; 2013 Dec; 20(6):1095-105. PubMed ID: 22605788
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Criteria influencing the choice of starting insulin regimen in patients with type 2 diabetes in routine clinical practice: baseline data from the Algerian cohort of the A₁chieve study.
    Malek R; Arbouche Z; Bachaoui M; Zinai S; Dahaoui A; Senoussaoui S; Salah-Mansour A
    Diabetes Res Clin Pract; 2013 Aug; 101 Suppl 1():S45-9. PubMed ID: 23958572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Exenatide convinces in a six-month study: HbA1c sunk significantly].
    MMW Fortschr Med; 2009 May; 151(19):51. PubMed ID: 19827448
    [No Abstract]   [Full Text] [Related]  

  • 53. Patient and Provider Factors Affecting Clinical Inertia in Patients With Type 2 Diabetes on Metformin Monotherapy.
    Mahabaleshwarkar R; Gohs F; Mulder H; Wilkins N; DeSantis A; Anderson WE; Ejzykowicz F; Rajpathak S; Norton HJ
    Clin Ther; 2017 Aug; 39(8):1658-1670.e6. PubMed ID: 28689692
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changes in the Prescription of Glucose-Lowering Medications in Patients With Type 2 Diabetes Mellitus After a Cardiovascular Event: A Call to Action From the DATAFILE Study.
    Fadini GP; Frison V; Simioni N; Lapolla A; Gatti A; Bossi AC; Del Buono A; Fornengo P; Gottardo L; Laudato M; Perseghin G; Bonora E; Avogaro A
    J Am Heart Assoc; 2019 Jul; 8(14):e012244. PubMed ID: 31269877
    [TBL] [Abstract][Full Text] [Related]  

  • 55. American College of Physicians diabetes guidelines attempt to turn back the clock, conflating good HbA1c with hypoglycemia.
    Bloomgarden Z; Einhorn D; Handelsman Y; Misra A; Zonszein J; Grunberger G; Jellinger PS; Garber AJ
    J Diabetes; 2018 Aug; 10(8):618-620. PubMed ID: 29655268
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical inertia in the treatment of hyperglycemia in type 2 diabetes patients in primary care.
    Mata-Cases M; Benito-Badorrey B; Roura-Olmeda P; Franch-Nadal J; Pepió-Vilaubí JM; Saez M; Coll-de-Tuero G;
    Curr Med Res Opin; 2013 Nov; 29(11):1495-502. PubMed ID: 23944631
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Route to improving Type 1 diabetes mellitus glycaemic outcomes: real-world evidence taken from the National Diabetes Audit.
    Heald AH; Livingston M; Fryer A; Moreno GYC; Malipatil N; Gadsby R; Ollier W; Lunt M; Stedman M; Young RJ
    Diabet Med; 2018 Jan; 35(1):63-71. PubMed ID: 29120503
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Idle thoughts from an addled mind. All roads lead to...
    Service FJ
    Endocr Pract; 2005; 11(3):208. PubMed ID: 16239211
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug utilization of oral hypoglycemic agents in a university teaching hospital in India.
    Sultana G; Kapur P; Aqil M; Alam MS; Pillai KK
    J Clin Pharm Ther; 2010 Jun; 35(3):267-77. PubMed ID: 20831529
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prescribing Paradigm Shift? Applying the 2019 European Society of Cardiology-Led Guidelines on Diabetes, Prediabetes, and Cardiovascular Disease to Assess Eligibility for Sodium-Glucose Cotransporter 2 Inhibitors or Glucagon-Like Peptide 1 Receptor Agonists as First-Line Monotherapy (or Add-on to Metformin Monotherapy) in Type 2 Diabetes in Scotland.
    Caparrotta TM; Blackbourn LAK; McGurnaghan SJ; Chalmers J; Lindsay R; McCrimmon R; McKnight J; Wild S; Petrie JR; Philip S; McKeigue PM; Webb DJ; Sattar N; Colhoun HM;
    Diabetes Care; 2020 Sep; 43(9):2034-2041. PubMed ID: 32581068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.